GL1X · GenesisL1 explorer

Ligand · NGU

NGU · U-58872, hydroxy derivative of nogalamycin

NGU, U-58872, hydroxy derivative of nogalamycin (C39 H49 N O17, 803.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…

Component
NGU
Formula
C39 H49 N O17
Class
ligand
Structures
2
PDB entries
1

Binding sites

NGU in 2 structures; the first of them:

  • 1D22 · Binding of the antitumor drug nogalamycin and its derivatives to DNA: structural… · NGU B13 · binds DT3, AS4, 5CM5, DG6, 5CM7, DG8, DT9, AS10
  • 1D22 · Binding of the antitumor drug nogalamycin and its derivatives to DNA: structural… · NGU B13 · binds DT3, AS4, 5CM5, DG6, 5CM7, DG8, DT9, AS10

Residues it binds most

5CM 4, AS 4, DG 4, DT 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.